𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum HER2 levels determined by two methods in patients with metastatic breast cancer

✍ Scribed by Naoki Hayashi; Seigo Nakamura; Yasuharu Tokuda; Hiroshi Yagata; Atsushi Yoshida; Hidekazu Ota; Gabriel N. Hortobagyi; Massimo Cristofanilli; Naoto T. Ueno

Publisher
Springer
Year
2011
Tongue
English
Weight
264 KB
Volume
17
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum epidermal growth factor receptor/H
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer
✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a